Also, an intriguing high proportion of PCNSL have genetic lesions that potentially avoid being recognized by T-cells, namely HLA loses and PD-L1/2 amplifications found in up to 80% of patients [14]. This evidence concerns the gene CD274 and primary central nervous system lymphoma.